Tahir Siddique (2025) “Efficacy and Safety of Once-Weekly Semaglutide versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial”, Journal of Health, Wellness and Community Research, 3(1), pp. 1–8. doi:10.61919/qxt0b644.